J Kent Wagner
Family Medicine · Palmyra, PANPI 1184689648
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 332 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,024 and has fallen 97.5% since, to $50 in 2022.
Across 332 payments — averaging $13.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$647
- GSK$387
- AstraZeneca$385
- Takeda Pharmaceuticals U.S.A., Inc.$372
- AbbVie$265
- Amgen$260
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,27698%
- Education$932%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $647 |
| GSK | 49 | $387 |
| AstraZeneca | 22 | $385 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $372 |
| AbbVie(2 entities) | 18 | $265 |
| Amgen | 21 | $260 |
| Pfizer | 23 | $221 |
| Amarin Pharma, Inc. | 9 | $160 |
| Otsuka America Pharmaceutical, Inc. | 10 | $156 |
| Astellas Pharma US Inc | 6 | $153 |
| Johnson & Johnson | 8 | $152 |
| Novartis | 8 | $149 |
| Biohaven Pharmaceuticals, Inc. | 10 | $134 |
| Lilly USA, LLC | 7 | $106 |
| Teva Pharmaceuticals USA, Inc. | 6 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Boehringer Ingelheim | 5 | $73 |
| Kowa Pharmaceuticals America, Inc. | 5 | $66 |
| Genentech USA, Inc. | 4 | $66 |
| Sanofi-aventis U.S. LLC | 5 | $60 |
| Daiichi Sankyo Inc. | 3 | $55 |
| Merck | 3 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 5 | $40 |
| Dexcom, Inc. | 2 | $33 |
| Abbott | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Bayer | 1 | $16 |
| Zealand Pharma US, Inc. | 1 | $15 |
| Mannkind Corporation | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$4,369 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Palmyra
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.